Renalytix plc - Sponsored ADR
RNLXY Healthcare Health Information Services
Renalytix plc - Sponsored ADR’s revenue for fiscal 2025 (year ended June 2025) was $3.0 million, up 30.4% from fiscal 2024. Operating cash flow growth for three consecutive years.
Follow RNLXY
Renalytix plc - Sponsored ADR (RNLXY) EV/Sales
As of 16 October 2026, Renalytix plc - Sponsored ADR (RNLXY) trades at a EV/Sales of 2.5×. Over the past ten years it has ranged from 0.0× (June 2021) to 19,374× (July 2021); the current reading is higher than 24% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 103× | (30.20%) |
| FY2024 | 147× | (83.32%) |
| FY2023 | 883× | 19.35% |
| FY2022 | 740× | (95.69%) |
| FY2021 | 17,186× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2024 | 118× | (19.75%) |
| Jun 2024 | 147× | (67.52%) |
| Mar 2024 | 454× | 111.63% |
| Dec 2023 | 214× | (64.95%) |
| 13 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| HLTHQ Cue Health Inc. compare | −1.1× |
| ZCMD Zhongchao Inc. compare | −0.4× |
| ETAOF ETAO International Co., Ltd. compare | n/m |
| BEAT HeartBeam, Inc. compare | n/m |
| HCTI Healthcare Triangle, Inc. compare | 0.4× |
| RNLXY Renalytix plc - Sponsored ADR | 2.5× |
| BFRG Bullfrog AI Holdings Inc. compare | 7.0× |
| MGRX Mangoceuticals, Inc. compare | 15.6× |
| ONMD OneMedNet Corporation compare | 18.2× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)